Visualization of Monoarnine Oxidase in Human Brain

Advances in Pharmacology

Volumn 42, Issue C, 1997, Pages 304-307

  Fowler, J S ^a   Volkow, N D ^a   Wang, G J ^a   Pappas, N ^a   Shea, C ^a   MacGregor, R R ^a   Logan, J ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956738809     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60750-4     Document Type: Article

References (6)

1. Strolin Benedetti M., and Dostert P. Monoamine oxidase, brain ageing and degener ative diseases. Biochem. Pharmacol. 38 (1989) 555-561
2. Terry R.D., DeTeresa R., and Hansen L.A. Neocortical cell counts in normal human adult aging. Ann. Neurol. 21 (1987) 530-539
3. 11C]L-deprenyl-D2 for MAO B mapping in human brain. J. Nucl. Med. 36 (1995) 1255-1262
4. Fowler C.J., Wiberg A., Oreland L., Marcusson J., and Winblad B. The effect of age on the activity and molecular properties of human brain monoamine oxidase. J. Neural Transm. 49 (1980) 1-20
5. 3H]idazoxan binding sites (I2-imidazoline sites) in the human brain: Strong correlation of I2 with monoamine oxidase B sites. J. Neurochem. 61 (1993) 881-889
6. Fowler J.S., Volkow N.D., Wang G.J., Pappas N., Logan J., MacGregor R., Alexoff D., Shea C., Schlyer D., Wolf A.P., Warner D., Zezulkova I., and Cilento R. Inhibition of monoamine oxidase B in the brains of smokers. Nature 379 (1996) 733-736